Practice parameters for the surveillance follow-up of patients with colon and rectal cancer

Diseases of the Colon and Rectum

Volumn 47, Issue 6, 2004, Pages 807-817

  Anthony, Thomas ^a   Simmang, Clifford ^a   Hyman, Neil ^a   Buie, Donald ^a   Kim, Donald ^a   Cataldo, Peter ^a   Orsay, Charles ^a   Church, James ^a   Otchy, Daniel ^a   Cohen, Jeffery ^a   Perry, W Brian ^a   Dunn, Gary ^a   Rafferty, Janice ^a   Ellis, C Neal ^a   Rakinic, Jan ^a   Fleshner, Phillip ^a   Stahl, Thomas ^a   Gregorcyk, Sharon ^a   Ternent, Charles ^a   Kilkenny, John W ^a   Whiteford, Mark ^a   more..

^a American Society of Colon and Rectal Surgeons   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; CANCER PATIENT; CANCER SURGERY; CLINICAL PRACTICE; CLINICAL TRIAL; COLON CANCER; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PATIENT CARE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; REVIEW;

EID: 2542595560     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-0519-x     Document Type: Review

References (54)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
2. Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg KG. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 1995;38:619-26.
3. Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997;84: 666-9.
4. Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 1995; 130:1062-7.
5. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998;114:7-14.
6. Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum 1998;41:1127-33.
7. Rosen M, Chan L, Beart RW, Vukasin P, Anthone G. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum 1998;41:1116-26.
8. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow-up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002;324:813-6.
9. Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbema JD, van de Velde CJ. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 1994;219:174-82.
10. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database System Review, 2002:CD002200.
11. Graham RA, Wang S, Catalano PJ, Haller DG. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. Ann Surg 1998;228:59-63.
12. Virgo KS, Vernava AM, Longo WE, McKirgan LW, Johnson FE. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA 1995;273:1837-41.
13. Norum J, Olsen JA. A cost-effectiveness approach to the Norwegian follow-up programme in colorectal cancer. Ann Oncol 1997;8:1081-7.
14. Stiggelbout AM, de Haes JC, Vree R, et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer 1997;75:914-20.
15. Kjeldsen BJ, Thorsen H, Whalley D, Kronborg O. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol 1999;34:509-15.
16. Goldberg RM, Fleming TR, Tangen CM, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998;129:27-35.
17. Peethambaram P, Weiss M, Loprinzi CL, et al. An evaluation of postoperative follow-up tests in colon cancer patients treated for cure. Oncology 1997;54:287-92.
18. Hemminki K, Li X, Dong C. Second primary cancers after sporadic and familial colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001;10:793-8.
19. McCredie M, Macfarlane GJ, Bell J, Coates M. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991. Cancer Epidemiol Biomarkers Prev 1997;6:155-60.
20. Graffner H, Hultberg B, Johansson B, Moller T, Petersson BG. Detection of recurrent cancer of the colon and rectum. J Surg Oncol 1985;28:156-9.
21. Cooper EH, Turner R, Steele L, Mackay AM. The contribution of serum enzymes and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer. Br J Cancer 1975;31:111-7.
22. Ohlsson B, Tranberg KG, Lundsted C, Ekberg H, Hederstrom E. Detection of hepatic metastases in colorectal cancer: a prospective study of laboratory and imaging methods. Eur J Surg 1993;159:275-81.
23. Rocklin MS, Senagore AJ, Talbott TM. Role of carcino-embryonic antigen and liver function tests in the detection of recurrent colorectal cancer. Dis Colon Rectum 1991;34:794-7.
24. Ahlquist DA, Wieand HS, Moertel CG, et al. Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and HemoQuant tests. JAMA 1993;269:1262-7.
25. Jahn H, Joergensen OD, Kronborg O, Fenger C. Can Hemoccult-II replace colonoscopy in surveillance after radical surgery for colorectal cancer and after polypectomy? Dis Colon Rectum 1992;35:253-6.
26. McCall JL, Black RB, Rich CA, et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 1994;37:875-81.
27. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993;270:943-7.
28. Northover JM. Carcinoembryonic antigen and recurrent colorectal cancer. Br J Surg 1985;72:S44-6.
29. Kronborg O. Optimal follow-up in colorectal cancer patients: what tests and how often? Semin Surg Oncol 1994;10:217-24.
30. Denstman F, Rosen L, Khubchandani IT, Sheets JA, Stasik JJ, Riether RD. Comparing predictive decision rules in postoperative CEA monitoring. Cancer 1986;58:2089-95.
31. Wanebo HJ, Lianeras M, Martin T, Kaiser D. Prospective monitoring trial for carcinoma of the colon and rectum after surgical resection. Surg Gynecol Obstet 1989;169: 479-87.
32. Minton J, Hoehn J, Gerber D. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985;55:1284-90.
33. Anonymous. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. J Clin Oncol 1996;14:2843-77.
34. Bast RC, Ravdin P, Hayes DF, et al. Update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1865-78.
35. Howell JD, Wotherspoon H, Leen E, Cooke TC, McArdle CS. Evaluation of a follow-up program after curative resection for colorectal cancer. Br J Cancer 1999;79:308-10.
36. Stomper PC, D'Souza DJ, Bakshi SP, Rodriguez-Bigas M, Burke PA, Petrelli NJ. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-95m-IMMU-4 monoclonal antibody scanning and CT. Radiology 1995;197:688-92.
37. Lacic M, Bokulic T, Lukac J, Baum RP, Kusic Z. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up. Nucl Med Commun 1999;20:859-65.
38. Doerr RJ, Herrera L, Abdel-Nabi H. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal carcinoma. Cancer 1993;71:4241-7.
39. Huebner RH, Park KC, Shepherd JE, et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000; 41:1177-89.
40. Anthony T, Fleming JB, Bieligk SC, et al. Postoperative colorectal cancer surveillance. J Am Coll Surg 2000;190: 737-49.
41. Desch CE, Benson AB, Smith TJ, et al. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol 1999;17: 1312-21.
42. Fleischer DE, Goldberg SB, Browning TH, et al. Detection and surveillance of colorectal cancer. JAMA 1989; 261:58C-5.
43. Lohnert M, Doniec JM, Kovacs G, Schroder J, Dohrmann P. New method of radiotherapy for anal cancer with three-dimensional tumor reconstruction based on endoanal ultrasound and ultrasound-guided afterloading therapy. Dis Colon Rectum 1998;41:169-76.
44. Mascagni D, Corbellini L, Urciuoli P, Di Matteo G. Endoluminal ultrasound for early detection of local recurrence of rectal cancer. Br J Surg 1989;76:1176-80.
45. Waizer A, Powsner E, Russo I, et al. Prospective comparative study of magnetic resonance imaging versus transrectal ultrasound for preoperative staging and follow-up of rectal cancer: preliminary report. Dis Colon Rectum 1991;34:1068-72.
46. Tornqvist A, Ekelund G, Leandooer L. The value of intensive follow-up after curative resection for colorectal carcinoma. Br J Surg 1982;69:725-8.
47. Vernava AM, Longo WE, Virgo KS, Coplin MA, Wade TP, Johnson FE. Current follow-up strategies after resection of colon cancer: results of a survey of the members of The American Society of Colon and Rectal Surgeons. Dis Colon Rectum 1994;37:573-83.
48. Virgo KS, Wade TP, Longo WE, Coplin MA, Vernava AM, Johnson FE. Surveillance after curative colon cancer resection: practice patterns of surgical subspecialists. Ann Surg Oncol 1995;2:472-82.
49. Tate JJ, Rawlinson J, Royle CT, et al. Pre-operative or post-operative colonoscopy examination for synchronous lesions in colorectal cancer. Br J Surg 1988;75: 1016-8.
50. Sugrue M, Black RB, Watts J, Toouli J. Peri-operative colonoscopy detects synchronous tumors in patients with colorectal cancer. ANZ J Surg 1991;61:25-8.
51. Cali RL, Pitsch RM, Thorson A, et al. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 1993;36:388-93.
52. Chen F, Stuart M. Colonoscopic follow-up of colorectal carcinoma. Dis Colon Rectum 1994;37:568-72.
53. Simmang CL, Senatore P, Lowry A, et al. Practice parameters for detection of colorectal neoplasms. The Standards Committee, The American Society of Colon and Rectal Surgeons. Dis Colon Rectum 1999;42:1123-9.
54. Winawer SJ. Appropriate intervals for surveillance. Gastrointest Endosc 1999;49:S63-6.